Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Hematology | Trauma (Emergency, Injury, Surgery)
Hemorrhage Clinical Trials
A listing of Hemorrhage medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : The University of Alabama at Birmingham
Aspirin in Reducing Events in the Elderly
Birmingham : Nycomed Investigational Site
Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery
Birmingham : Cardio-Thoracic Surgeons, PC
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Birmingham : University of Alabama at Birmingham
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Birmingham :
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
Arizona
Phoenix : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Phoenix : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Phoenix : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Phoenix :
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
California
Loma Linda : Loma Linda University Medical Center
Effects of CoSeal on Bleeding & Adhesions in Pediatric Heart Surgery
Long Beach : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Long Beach : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Los Angeles : Cedars-Sinai Medical Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Los Angeles : University of California Los Angeles
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
View More »
Los Angeles : Nycomed Investigational Site
Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery
Los Angeles : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Los Angeles : University of Southern California, Keck School of Medicine
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Los Angeles : University of Southern California/Norris Comprehensive Cancer Center
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Los Angeles : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Orange : Vascular Interventional Specialists of Orange County
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Palo Alto : Stanford University Medical Center
Adjunctive Application of BioFoam Surgical Matrix in Liver Surgery
Palo Alto : Stanford University
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Pasadna : Lotus Clinical Research, LLC
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Sacramento : Mercy General Sacramento
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Sacramento : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Sacramento : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Sacramento : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Sacramento : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
San Francisco : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Torrance : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Colorado
Aurora : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Boulder : Boulder Neurological Institute
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Durango : Spine Colorado
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Connecticut
Hartford : Hartford Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
New Haven : Yale University
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
District of Columbia
Washington : Georgetown University Hospital
Albumin for Intracerebral Hemorrhage Intervention
Washington : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Washington : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Washington :
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
Washington : Georgetown University
Wilate in Subjects With Von Willebrand Disease Who Undergo Surgery
View More »
Washington DC : Georgetown University
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Washington, DC : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Washington, DC : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Washington, DC : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Washington, DC : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Florida
Gainesville : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Gainsville : University of Florida Department of Aging and Geriatrics
Aspirin in Reducing Events in the Elderly
Jacksonville : Mayo Clinic, Jacksonville
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Jacksonville : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Jacksonville : Baptist Health Medical Center
The Evicel Post-Authorization Surveillance Study
View More »
Miami : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Miami : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Orlando : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Orlando : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Orlando : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Sarasota : Intercoastal Medical Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Tampa : University of South Florida
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Tampa : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Tampa : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Tampa : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Georgia
Augusta : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Augusta : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Augusta : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Augusta : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Augusta : Novo Nordisk Clinical Trial Call Center
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
View More »
Austell : Nycomed Investigational Site
Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery
Idaho
Boise : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Boise : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Illinois
Chicago : Rush Alzheimer's Disease Center
Aspirin in Reducing Events in the Elderly
Chicago : Rush University
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Chicago : University of Chicago
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Chicago : University of Illinois at Chicago
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Chicago : Northwestern University
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
View More »
Oak Lawn : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Peoria : OSF Stroke Center
IV Double and Triple Concentrated Nicardipine for Stroke and ICH
Skokie : NorthShore University HealthSystem
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Springfield : Nycomed Investigational Site
Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery
Springfield : Southern Illinois University School of Medicine
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Springfield :
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
Indiana
Carmel : Indiana Spine Group
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Indianapolis : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Iowa
Iowa City : Novo Nordisk Clinical Trial Call Center Updated
A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A
Iowa City : University of Iowa
Aspirin in Reducing Events in the Elderly
Iowa City : University of Iowa
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Iowa City : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Iowa City : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
View More »
Iowa City : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Iowa City : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Iowa City :
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
Kentucky
Lexington : Nycomed Investigational Site
Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery
Lexington : Bluegrass Orthopedics
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Lexington :
Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Parenchymous Tissue Open Surgeries
Lexington :
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
Louisiana
New Orleans : Novo Nordisk Clinical Trial Call Center Updated
A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A
New Orleans : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
New Orleans : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Maryland
Baltimore : Johns Hopkins University
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Baltimore : University of Maryland
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Baltimore : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Baltimore : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Baltimore : Johns Hopkins University
Phase II Clinical Trial on Treatment of Intraventricular Hemorrhage
View More »
Baltimore : University of Maryland Medical Systems
Phase II Clinical Trial on Treatment of Intraventricular Hemorrhage
Baltimore : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Randallstown : Northwest Hospital
Intrauterine Use of FloSeal: Is it Safe and Useful?
Massachusetts
Boston : Massachusetts General Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Boston : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Boston : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Boston : Massachusetts General Hospital
Pilot Study of Model Based Iterative Reconstruction Using 64-Slice
Burlington : Lahey Clinic Medical Center
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Michigan
Detroit : Wayne State University
Aspirin in Reducing Events in the Elderly
Detroit : Henry Ford Health System
Aspirin in Reducing Events in the Elderly
Detroit : Henry Ford Health System
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Detroit : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Detroit : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
View More »
Detroit : Wayne State University
Phase II Clinical Trial on Treatment of Intraventricular Hemorrhage
Detroit : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Detroit : Henry Ford Hospital
Safety and Efficacy Study of Clevidipine to Control Hypertension in Patients Admitted With Aneurysmal Subarachnoid Hemorrhage
Detroit : Henry Ford Health System
Wilate in Subjects With Von Willebrand Disease Who Undergo Surgery
East Lansing : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
East Lansing : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Kalamazoo : Borgess Research Institute
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Royal Oak : Beaumont Health System
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Minnesota
Minneapolis : Health Partners Research Foundation
Aspirin in Reducing Events in the Elderly
Minneapolis : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Minneapolis : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Minneapolis : Novo Nordisk Clinical Trial Call Center
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
St. Paul : Phalen Village Clinic
Aspirin in Reducing Events in the Elderly
Missouri
Springfield : Springfield Neurological and Spine Institute
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
St. Louis : St. Louis University
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
St. Louis : Washington University School of Medicine
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Nebraska
Omaha : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Omaha : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Nevada
Las Vegas : William Muir MD Spine Surgery
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Las Vegas : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
New Jersey
Camden : Cooper University Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Edison : New Jersey Neuroscience Institute at JFK
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
New Brunswick : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
New Brunswick : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
New Brunswick : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
View More »
Newark : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Newark : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Newark : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
New Mexico
Albuquerque : Lovelace Clinic Foundation
Aspirin in Reducing Events in the Elderly
New York
Brooklyn : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Buffalo : University of Buffalo
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Manhasset : Northshore University Hospital Long Island
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
New York : Columbia University Medical Center
Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage
New York : Columbia University
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
View More »
New York : Mount Sinai Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
New York : Nycomed Investigational Site
Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery
New York : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
New York : Mt. Sinai Medical Center
Phase II Clinical Trial on Treatment of Intraventricular Hemorrhage
New York : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
New York : Novo Nordisk Clinical Trial Call Center
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
New York City : New York-Presbyterian Hospital/Columbia University
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Rochester : Mary M Gooley Hemophilia Center
Wilate in Subjects With Von Willebrand Disease Who Undergo Surgery
Staten Island : Staten Island University Hosptial
Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation
Syracuse : SUNY Upstate Medical Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Syracuse : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Syracuse : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Valhalla : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Valhalla : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
North Carolina
Chapel Hill : University of North Carolina Chapel Hill
Aspirin in Reducing Events in the Elderly
Chapel Hill : The University of North Carolina at Chapel Hill
Lovaza's Effect on the Activation of Platelets
Charlotte : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Durham : Duke University Hospital Medical Center
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Durham : Duke University Medical Center
Pilot Study of Model Based Iterative Reconstruction Using 64-Slice
View More »
Greensboro : Wake Forest University Baptist Medical Center
Aspirin in Reducing Events in the Elderly
Winston-Salem : Wake Forest University Baptist Medical Center
Aspirin in Reducing Events in the Elderly
Winston-Salem : Wake Forest School of Medicine
Aspirin in Reducing Events in the Elderly
Winston-Salem : Wake Forest University
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Ohio
Cincinnati : University of Cincinnati
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Cincinnati : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Cincinnati : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Cincinnati : University of Cincinnati
Phase II Clinical Trial on Treatment of Intraventricular Hemorrhage
Cincinnati : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
View More »
Cleveland : Case-Western Reserve University Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Cleveland : Cleveland Clinic Foundation
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Cleveland : Cleveland Clinic Foundation
Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDE
Dayton : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Toledo :
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
Oklahoma
Tulsa : The University of Oklahoma - Tulsa
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Oregon
Portland : Providence Stroke Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Portland : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Portland : Oregon Health & Science University Hospital & Clinics
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Portland : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Pennsylvania
Hershey : Penn State Hershey Medical Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Monroeville :
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
Philadelphia : Temple University Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Philadelphia : Albert Einstein Medical Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Philadelphia : Thomas Jefferson University Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
View More »
Philadelphia : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Philadelphia : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Pittsburg :
Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Soft Tissue Open Surgeries
Pittsburgh : University of Pittsburgh Health Sciences Research Center
Aspirin in Reducing Events in the Elderly
Pittsburgh : Allegheny General Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Pittsburgh : University of Pittsburgh Medical Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Pittsburgh : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Pittsburgh : UPMC-Presbyterian Hospital
Pre-emptive Hemodynamic Optimization of High Risk Patients Undergoing Elective Major Surgical Procedures
Pittsburgh :
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
South Carolina
Charleston : Medical University of South Carolina
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Charleston : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Charleston : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Charleston : Medical University of South Carolina
Phase II Clinical Trial on Treatment of Intraventricular Hemorrhage
Charleston : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Tennessee
Memphis : Site Reference ID/Investigator# 57561
Safety and Efficacy Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids
Memphis : Methodist Healthcare, University Hospital
The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy
Nashville : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Nashville : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Nashville : Novo Nordisk Clinical Trial Call Center
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
Texas
Dallas : University of Texas Southwestern Medical Center at Dallas
Aspirin in Reducing Events in the Elderly
Dallas : University of Texas, Southwestern, Dallas
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Fort Worth : University of North Texas Health Sciences Center
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Galveston : Nycomed Investigational Site
Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery
Houston : University of Texas, Houston
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
View More »
Houston : Nycomed Investigational Site
Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery
Houston : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Houston : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Houston : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Houston :
Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Soft Tissue Open Surgeries
Houston : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Houston :
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
Houston : Novo Nordisk Clinical Trial Call Center
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
Houston : Gulph States Hemophilia and Thrombophilia Center
Wilate in Subjects With Von Willebrand Disease Who Undergo Surgery
McAllen : South Texas College
Aspirin in Reducing Events in the Elderly
McKinney :
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
San Antonio : UT Health Science Center at San Antonio
Aspirin in Reducing Events in the Elderly
San Antonio : University of Texas, San Antonio
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Utah
Salt Lake City : University of Utah
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Sandy : Physician's Research Options
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Virginia
Charlottesville : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Charlottesville : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Charlottesville : University of Virginia Health System Medical Center
Safety and Pharmacokinetic Evaluation of Nitrite for Prevention of Cerebral Vasospasm
Richmond : Virginia Commonwealth University
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Richmond : Virginia Commonwealth University
Phase II Clinical Trial on Treatment of Intraventricular Hemorrhage
Washington
Bellevue : Nycomed Investigational Site
Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery
Bellevue : Overlake Hospital Medical Center
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Olympia : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Seattle : Swedish Medical Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Seattle : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
View More »
Seattle : Virginia Mason Medical Center
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Spokane : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Spokane : Northwest Orthopaedic Specialists, P.S.
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Tacoma : Multicare Neuroscience Center of Washington
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Wisconsin
Milwaukee : Children's Hospital of Wisconsin
Antithrombin III Supplementation for Cardiopulmonary Bypass in Neonates
Milwaukee : Medical College of Wisconsin
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Miwaukee : Froedtert Memorial Lutheran Hospital
Pilot Study of Model Based Iterative Reconstruction Using 64-Slice
Australia
Adelaide : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Parkville :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Perth : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Austria
Graz : Dept. of Neurosurgery, Medical University of Graz Updated New
A New Multi-parameter Neuromonitoring System to Save Patients' Lives in Stroke and Brain Injury
Graz :
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Vienna : Allgemeines Krankenhaus der Stadt Wien - Universitätskliniken
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
Belgium
Bonheiden :
A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery
Brussells : Militair Hospitaal Koningin Astrid
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Brussels :
A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery
Bruxelles : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Bruxelles : Clinique du Parc Leopold, Service de Neurochirurgie
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
View More »
Bruxelles : Hopital Erasme, Service de Neurochirurgie
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Flemish Brabant : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Gent : Universitair Ziekenhuis Gent, Gasto-Intestinale Heelkunde
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Hassalt :
A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery
Leuven :
A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery
Leuven : Universitair Ziekenhuis Leuven, Abdominale Heelkunde
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Brazil
Campinas :
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Campinas Sao Paulo : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Rio de Janeiro : Updated
A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A
Bulgaria
Sofia :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Canada
Edmonton : University of Alberta
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Halifax : Queen Elizabeth II Health Sciences Centre
Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding
Hamilton : Hamilton Health Science
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
London : London University Health Sciences Centre
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Montreal : Montreal Neurological Institute at McGill University
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
View More »
Montreal : McGill University Health Center
Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding
Montreal : Royal Victoria Hospital
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Montreal : Jewish General Hospital
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Toronto :
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
Toronto : Toronto General Hospital
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
Toronto : University of Toronto - St. Michael's Hospital
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
Vancouver : St. Paul's Hospital
Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding
Winnipeg : St. Boniface General Hospital
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
China
Beijing :
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Beijing :
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Changchun :
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Changsha :
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Chengdu :
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
View More »
Chongqing :
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Dalian :
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Guangzhou : Guangzhou Southern Hospital
CavatermTM vs TCRE in Women With DUB
Guangzhou : Zhu Jiang Hospital
CavatermTM vs TCRE in Women With DUB
Guangzhou :
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Hengyang :
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Jinan :
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Nanning :
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Shanghai :
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Shenyang :
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Shijiazhuang :
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Tianjin :
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Wuhan :
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Xi'an :
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Croatia
Zagreb :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Zagreb :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Denmark
Århus N :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Copenhagen : Juliane Marie Centre, Rigshospitalet
Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial
Glostrup : Merck Sharp & Dohme
A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012)
Herlev : University Hospital of Herlev
Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial
Hilleroed : University Hospital of Hilleroed
Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial
View More »
Hvidovre : University Hospital of Hvidovre
Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial
Egypt
Cairo : Shoubra Maternity Hospital
Study About Patients Using Copper Intrauterine Device
Finland
Helsinki : HUCH Anaestesia and Surgery
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
France
Alencon : MEROUANI
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Amiens : LAIGLE
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Angers : CHU d'Angers
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Angoulême : CH d'Angoulême
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Annecy : SANTRE
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
View More »
Bordeaux : MOREL
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Bourg En Bresse : SEDILLOT
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Brest : HIA Clermont-Tonnerre
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Brest : Medical Intensive Care Unit
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Caen : BULEON
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Chambery : MIQUET
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Clamart : DEBIEN
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Clermont Ferrand : GUELON
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Clichy : PEASE
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Corbeil Essonne : CH de Corbeil Essonne
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Creteil : COOK
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Dijon : CHU de Dijon
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Dijon : NADJI
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
GAP : Vinsiniti
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Grenoble : DECLETY
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Kremlin-Bicêtre :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Kremlin-Bicêtre :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Le Kremlin Bicetre : Duranteau
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Lille : GARRIGUE
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Lyon :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Lyon : FLOCARD
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Marseille : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Marseille : GARCIN
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Metz : FAVIER
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Montauban : CH Montauban
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Montpellier : YUNG
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Montpellier : CHARBIT
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Morlaix : CH de Morlaix
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Nancy : AUDIBERT
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Nantes : CHUPIN
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Nice : ICHAI
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Nimes : LEFRANT
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Paris : Medical Intensive Care Unit
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Paris :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Paris : JOURNOIS
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Paris : LANGERON
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Paris : Mateo A Loris
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Pierre Benite : DAVID
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Poitiers : CHU de Poitiers
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Poitiers : Nanadoumgar
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Reims : LEPOUSE
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Rennes : Bleichner
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Rouen : GUITARD
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Saint Etienne : MARTIN
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Saint Malo : CH de St Malo
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Strasbourg : FREYS
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Toulon : MEAUDRE
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Toulouse : Service de neurologie
Amyloid Imaging and Cognitive Impairment After Intracerebral Hemorrhage
Toulouse : OLIVIER
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Tours : CHU de Tours
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Vannes : LEBAS
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Villefranche Sur Saone : JAULT
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Germany
Bad Abbach : Department of Orthopedic Surgery
Use of Etoricoxib Compared to Diclofenac in the Perioperative Treatment of Patients After Total Hip Arthroplasty
Berlin : Charité Universitätsmedizin Berlin
Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery
Berlin :
Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A
Bonn :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Bonn : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
View More »
Bonn :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Erlangen : Department of Neurosurgery, University of Erlangen
Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH)
Frankfurt am Main : Klinikum der J.-W.-Goethe-Universität
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
Freiburg :
A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery
Halle : University of Halle
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Hannover : Updated
A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A
Hannover :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Hannover :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Heidelberg : University of Heidelberg
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Leipzig :
A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery
Leipzig : University of Leipzig
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Mainz : University of Mainz
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Muenster : University Hospital Muenster
Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery
München : Technischen Universität München
A Prospective, Multi-Center, Single-Arm Study of the Veriset™ Hemostatic Patch in Controlling Bleeding in Soft Tissue
Munich : Klinikum der Universität München
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
Greece
Athens :
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Hong Kong
Hong Kong : Prince of Wales Hospital
Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding
Hong Kong : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Shatin, New Territories :
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Hungary
Debrecen :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Debrecen :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
India
Karnataka : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Maharashtra : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Pune : Sahyadri Specialty Hospital
Wilate in Subjects With Von Willebrand Disease Who Undergo Surgery
Vellore : Christian Medical College
Wilate in Subjects With Von Willebrand Disease Who Undergo Surgery
Israel
Beer Sheva : OB\GYN Soroka University Medical Center
Hemcon© Bandage for Postpartum Bleeding Due to the Multiple Vaginal Lacerations
Haifa : Rambam Medical Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Jerusalem : Hadassah Hebrew University Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Ramat-Gan : Chaim Sheba Medical Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Tel Aviv : Sourasky Medical Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Italy
Bologna : Policlinico S. Orsola Malpighi
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
Firenze :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Florence : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Milano :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Milano :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
View More »
Milano :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Milano : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Milano :
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
Milano : Fondazione Centro San Raffaele
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
Milano : Granda Ospedale Maggiore Policlinico
Wilate in Subjects With Von Willebrand Disease Who Undergo Surgery
Udine : Azienda Ospedaliera di Udine
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
Vicenza : Updated
A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A
Vicenza : ULSS6 Vicenza Ematologia
Wilate in Subjects With Von Willebrand Disease Who Undergo Surgery
Japan
Kasihara-City : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Kitakyushu : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Miyamae-ku : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Nagoya : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Shinjuku-ku : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
View More »
Shinjuku-ku, Tokyo :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Shinjuku-ku, Tokyo :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Suginami-ku : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Suginami-ku, Tokyo :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Suginami-ku, Tokyo :
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
Korea, Republic of
Ansan : Korea University Ansan Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Anyang : Hallym University Sacred Heart Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Bucheon : Soonchunhyang University Bucheon Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Busan : Pusan National University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Busan : Dong-A University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
View More »
Busan : Inje Univercity Heaundae Paik Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Busan : Inje University Pusan Paik Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Busan : Kosin University Gospel Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Changwon : Samsung changwon Medical Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Changwon : Chang Won Fatima hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Cheonan : Soonchunhyang University Cheonan Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Cheongju : Chungbuk National University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Chuncheon : Kangwon National University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Daegu : Daegu Fatima Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Daegu : Keimyung University Dongsan Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Daejeon :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Daejeon :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Daejon : Eulji University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Deagu : Dongsan Medical Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Deagu : Kyungpook National University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Deagu : Yeungnam University Medical Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Deagu : Deagu Catholic University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Deajeon : Deajeon St.Mary's Hospital, The Catholic University of Korea
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Deajeon : Chungnam National University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Goyang : Dongguk University International Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Goyang : Inje University Ilsan Paik Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Goyang-si : National Health Insurance Corporation Ilsan Hoapital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Guri : Hanyang University Guri Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
GwangJu : Chosun University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Gwangju : Chonnam National University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Gyeonggi-do : Kwandong University College of Medicine Myongji Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Iksan : Wonkwang University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Incheon : Gachon University Gil Hoapital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Inchon : Inha University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Jeonju-si : Chonbuk National University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Jinju : Gyeongsang National University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Pusan : Wallace Memorial Baptist Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seongnam : Seoul National University Bundang Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seongnam-si : Bundang Medical Center, CHA University
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Gangnam Severance Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Kangdong Sacred Heart Hospital, Hallym University
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Ewha Womans University Medical Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Asan Medical Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : National Medical Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Seoul National University Borame Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Konkuk Univ. Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Seoul Medical Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Seoul National University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Seoul St.Mary's Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Severance Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Soonchunhyang University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : St. Mary's Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Chung-Ang University Medical Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Eulji Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Hangang Sacred Heart Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Hanyang University Medical Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Inje University Sanggye Paik Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Kangbuk Samsung Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Kangnam Sacred Heart Hospital, Hallym University College of Medicine
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Korea University Anam Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Korea University Guro Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Kyung Hee University Medical Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Suwon : Ajou University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Uijeongbu : Uijeongbu St. Mary's Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Ulsan : Ulsan University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Wonju : Wonju Christian Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Latvia
Riga :
Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A
Macedonia, The Former Yugoslav Republic of
Skopje :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Skopje :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Malaysia
Kuala Lumpur :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Kuala Lumpur :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Kuala Lumpur :
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
Selangor Darul Ehsan :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Netherlands
Breda : Amphia Hospital
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Enschede : Medisch Spectrum Twente
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Groningen :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Groningen :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Groningen : University Medical Centre Groningen
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
View More »
Haarlem : Merck Sharp & Dohme BV
A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012)
Leiden : Leiden University Medical Center
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Nijmegen : Radboud University Medical Center
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Rotterdam : Erasmus Medical Center
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Utrecht :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Utrecht :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Velp : Rijnstate Arnhem
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Norway
Oslo :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Oslo :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Pakistan
Karachi, Sindh : Site Reference ID/Investigator# 77674
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Karachi, Sindh : Site Reference ID/Investigator# 77675
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Karachi, Sindh : Site Reference ID/Investigator# 77677
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Karachi, Sindh : Site Reference ID/Investigator# 77680
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Karachi, Sindh : Site Reference ID/Investigator# 77681
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
View More »
Lahore, Punjab : Site Reference ID/Investigator# 77695
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Lahore, Punjab : Site Reference ID/Investigator# 77696
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Lahore, Punjab : Site Reference ID/Investigator# 77691
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Lahore, Punjab : Site Reference ID/Investigator# 77699
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Multan, Punjab : Site Reference ID/Investigator# 77689
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Multan, Punjab : Site Reference ID/Investigator# 77684
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Multan, Punjab : Site Reference ID/Investigator# 77686
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Multan, Punjab : Site Reference ID/Investigator# 77687
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Panama
Pittsburgh : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Philippines
Manila : University of Santo Tomas
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Manila : Manila Doctors Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Pasig : The Medical City
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Quezon City : St. Luke's Medical Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Poland
Gdansk : Uniweryteckie Centrum Kliniczne
Wilate in Subjects With Von Willebrand Disease Who Undergo Surgery
Lodz : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Puerto Rico
San Juan : Puerto Rico Medical Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
San Juan : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
San Juan : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
San Juan : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Romania
Bucharest :
Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen
Timisoara : Louis Turcanu Emergency Clinical Children´s Hospital
Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen
Russian Federation
Irkutsk :
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Ivanovo :
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Krasnodar :
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Saint-Petersburg :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Saint-Petersburg :
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
View More »
Saint-Petersburg :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
South Africa
Cape Town : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Johannesburg : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Johannesburg : Hemophilia Comprehensive Care Center
Wilate in Subjects With Von Willebrand Disease Who Undergo Surgery
Parktown Johannesburg :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Parktown Johannesburg :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Spain
Barcelona : Vall d'Hebron University Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Barcelona : Bellvitge Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Barcelona : Hospital de la Santa Creu i Sant Pau
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Barcelona : Hospital Clinic i Provincial
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Barcelona : Hospital de Sabadell
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
View More »
Getafe : Hospital Universitario de Getafe
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Madrid :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Madrid :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Madrid :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Madrid :
Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A
Madrid :
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Madrid :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Palma de Mallorca : Hospital Son Dureta
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Pamplona : Clinica Universitaria de Navarra
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Santander : Hospital Universitario Marques de Valdecilla
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Sweden
Malmö :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Malmö :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Malmö : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Stockholm : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Switzerland
Meyrin : Hôpital de la Tour
A Randomized Clinical Evaluation of the BioFreedom™ Stent
Zurich : Neurointensive Care Unit, University Hospital Zurich Updated New
A New Multi-parameter Neuromonitoring System to Save Patients' Lives in Stroke and Brain Injury
Zurich : University of Zurich
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Zürich : Updated
A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A
Zürich :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
View More »
Zürich :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Taiwan
Tainan :
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Taipei :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Taipei :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Taipei :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Taipei :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
View More »
Taipei :
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
Taipei :
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Thailand
Bangkok :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Bangkok :
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Turkey
Adana :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Bornova-IZMIR :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Bornova-IZMIR :
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Kayseri :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Konya :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
View More »
Konya :
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
Ukraine
Donetsk : Updated
A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A
United Kingdom
Birmingham : Queen Elizabeth Hospital Birmingham
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Cambridge : Addenbrookes Hospital Vascular Department
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Cambridge : Papworth Hospital
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
Cambridgeshire : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Cardiff :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
View More »
Doncaster : Doncaster Royal Infirmary
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Doncaster : Doncaster Royal Infirmary Hospital
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Edgbaston : Queen Elizabeth Hospital Birmingham
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Edinburgh : Royal Infirmary of Edinburgh
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Epsom : South West London Elective Orthopaedic Center
Bipolar Sealer Aquamantys Use in Total Knee Replacement
Frimley : Frimley Park Hospital
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Hull : Hull Royal Infirmary
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Hull : Hull Royal Infirmary
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Leeds : Leeds General Infirmary
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Leeds : Leeds General Infirmary
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
London :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
London :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
London :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
London : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
London : King's College Hospital
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
London : King's College Hospital NHS Foundation Trust
Preoperative Intravitreal Ranibizumab for Persistent Diabetic Vitreous Haemorrhage:
London :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Newcastle upon Tyne : Newcastle General Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Newcastle upon Tyne : Freeman Hospital
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Newcastle upon Tyne : Freeman Hospital
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Oxford :
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
Southampton : University of Southampton Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Southampton : Southampton General Hospital
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
Tooting : St. George's Hospital
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Vietnam
Danang : Research Site
Survey of Non-Variceal Upper Gastro Intestinal Bleeding in Vietnamese Patients
Hanoi : Research Site
Survey of Non-Variceal Upper Gastro Intestinal Bleeding in Vietnamese Patients
HoChiMinh City : Research Site
Survey of Non-Variceal Upper Gastro Intestinal Bleeding in Vietnamese Patients
